Therefore, they explored the mechanism of ACADL-mediated cell growth inhibition and found that ACADL could inhibit activation of the Hippo/YAP pathway in HCC cells, thereby inhibiting the growth of HCC cells. Here, ACADL is linked to hepatocellular carcinoma.